Apr 09, 2025
1:13
For every 13 shares held, investors received 1. The price per share adjusted from $0.55 to $0.04.
The split itself did not change the total investment value.
Tempest Therapeutics, Inc. (TPST) trades on the NASDAQ Capital Market in the Biotechnology industry.
Tempest Therapeutics, Inc. company overviewThe latest split shown was on April 9, 2025. It was a 1-for-13 reverse split, so shareholders received 1 share for every 13 they held.
This history records 3 reverse splits between December 10, 2018 and April 9, 2025.